The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia
Abstract
Objective The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed. Method In a 6-week, randomized, multisite, parallel-group study of 51 nursing home patients with agitation and dementia, individualized doses of carbamazepine were compared with placebo. Except for a physician monitor and a pharmacist, all participants were blind to treatment. The primary outcome measures were the Brief Psychiatric Rating Scale (BPRS) and Clinical Global Impression (CGI) global improvement rating. Secondary measures included measures of behavior, aggression, cognition, functional status, staff time, safety, and tolerability. Intent-to-treat analysis was performed. Results The modal carbamazepine dose at 6 weeks was 300 mg/day, and a mean serum level of 5.3 micrograms/ml was achieved. The study was terminated after a planned interim analysis showed that carbamazepine provided more benefit than did placebo. Over 6 weeks the mean total BPRS score decreased 7.7 points for the carbamazepine group and 0.9 for the placebo group, and the weekly scores showed a gradual divergence between the two groups. CGI ratings showed global improvement in 77% of the patients taking carbamazepine and 21% of those taking placebo. Secondary analyses confirmed that the positive changes were due to decreased agitation and aggression. The drug was generally well tolerated, and no change in cognition or functional status occurred. The per…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two small trials of carbamazepine (n=51 and n=21) of less than six weeks’ duration showed some benefit for agitation and global clinical outcomes.143 144”
From Assessment and management of behavioral and psychological symptoms of dementia (2015) · cites this paper as [143]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540
The Overt Aggression Scale for the objective rating of verbal and physical aggression
Yudofsky, S. C., Silver, J., Jackson, W., Endicott, J., & Williams, D. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.35 · Cited by 1,214
Agitated Behaviors in the Elderly: I. A Conceptual Review
Cohen‐Mansfield, J., & Billig, N. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04302.x · Cited by 717
Agitated Behaviors in the Elderly: II. Preliminary Results in the Cognitively Deteriorated
Cohen‐Mansfield, J. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04303.x · Cited by 654
A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650
The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling.
Overall, J. E., & Gorham, D. R. (1988) · Cited by 586
Tariot, P. N., Mack, J. L., Patterson, M. B., Edland, S. D., Weiner, M., Fillenbaum, G. G., Blazina, L., Teri, L. L., Rubin, E. H., & Mortimer, J. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1349 · Cited by 426
Self-citationPrevalence of mental illness in a community nursing home
Rovner, B. W., Kafonek, S. D., Filipp, L., Lucas, M. J., & Folstein, M. F. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1446 · Cited by 364
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Reisberg B, Franssen E, Sclan SG: Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer's disease: a study of 120 patients using the BEHAVE-AD. Bull Clin Neuroscience 1989; 54:95–112
- Marx MS, Cohen-Mansfield J, Werner P: A profile of the aggressive nursing home resident. Behavior, Health, and Aging 1990; 1:65–73
- Chambers CA, Bain J, Rosbottom R, Ballinger BR, McLaren S: Carbamazepine in senile dementia and overactivity—a placebo controlled double blind trial. IRCS Med Sci 1982; 10:505–506
Cited by
Sorted by citations
Items 201–300 of 421
Finkel, S. I. (2001) · Springer eBooks · doi:10.1007/978-4-431-67897-7_32 · Cited by 10
Barry, J. J., Lembke, A., & Bullock, K. D. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500107 · Cited by 10
Evidence‐based pharmacological treatment of dementia
Emre, M., & Hanagasi, H. A. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00055.x · Cited by 10
Médicaments et mémoire : des interactions à connaître chez le sujet âgé
Caer-Frouard, M., Weill‐Engerer, S., & Piette, F. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74529-8 · Cited by 10
Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease
Tractenberg, R. E., Gamst, A. C., Weiner, M., Koss, E., Thomas, R. G., Teri, L. L., & Thal, L. J. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.441 · Cited by 10
The Primary Care of Alzheimer Disease
Rubin, C. D. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200612000-00004 · Cited by 10
Management of neuropsychiatric symptoms in dementia
Martin, M. S., & Mauléon, A. D. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch70 · Cited by 10
Rose, D., Lyketsos, C. G., Rosenberg, P. B., & Nowrangi, M. A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00788 · Cited by 12
Therapie von psychischen und Verhaltenssymptomen bei Demenz
Jessen, F., & Spottke, A. E. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3002-z · Cited by 10
Managing the Behavioral and Psychological Symptoms of Dementia
Mendez, M. F. (2022) · Current Treatment Options in Neurology · doi:10.1007/s11940-022-00715-6 · Cited by 11
The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry
Steffens, D. C., & Zdanys, K. F. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196 · Cited by 9
Banerjee, S., Farina, N., Henderson, C., High, J., Stirling, S., Shepstone, L., Fountain, J., Ballard, C. G., Bentham, P., Burns, A. S., et al. (2023) · Health Technology Assessment · doi:10.3310/vpdt7105 · Cited by 10
Management of behavioural and psychological symptoms of dementia and acquired brain injury
Sadavoy, J., Lanctôt, K. L., & Deb, S. S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544392.012 · Cited by 9
Aggression, Gewalt, Amok, Stalking
Bogerts, B., Peter, E., & Schiltz, K. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_81 · Cited by 9
Cheng, H. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.06.005 · Cited by 9
New Uses for Lithium and Anticonvulsants
Salzman, C. (2003) · Harvard Review of Psychiatry · doi:10.1080/hrp.11.5.230.244 · Cited by 9
The Application of Evidence-Based Principles of Care in Older Persons (Issue 5): Alzheimer’s Disease
Zarowitz, B. J. M., Stefanacci, R. G., Hollenack, K. A., O’Shea, T., Gruber, J., & Tangalos, E. G. (2006) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2006.08.008 · Cited by 9
What Has Changed in Clinical Drug Trials for Behavioral and Psychological Symptoms of Dementia?
Finkel, S. I. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200007171 · Cited by 9
Randomized Controlled Trials in Long-Term Care Residents with Dementia: A Systematic Review
Mills, E. J., & Chow, T. W. (2003) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70388-6 · Cited by 9
Long-Term Management of Dementia
(2016) · CRC Press eBooks · doi:10.3109/9781420020250 · Cited by 8
Common Psychiatric Problems in Cognitively Impaired Older Patients
Wang, L. Y., Borisovskaya, A., Maxwell, A. L., & Pascualy, M. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.04.002 · Cited by 8
Prescribing patterns for psychotic and behavioural symptoms in dementia: a national survey
Scott, K., Lawrence, R., Duggal, A., Darwin, C., Brooks, E., & Christodoulou, G. (2002) · Psychiatric Bulletin · doi:10.1192/pb.26.8.288 · Cited by 8
Psychiatric issues in non-Alzheimer dementias
Aarsland, D., & Ballard, C. G. (2004) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2004.04.006 · Cited by 8
Psychiatric symptoms of dementia: Treatable, but no silver bullet
Schwab, W., Messinger‐Rapport, B. J., & Franco, K. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76a.07270 · Cited by 8
Management of behavioural symptoms of dementia in a specialized unit care
Saidlitz, P., Sourdet, S., Voisin, T., & Vellas, B. J. (2016) · Psychogeriatrics · doi:10.1111/psyg.12193 · Cited by 8
Mulsant, B. H., & Pollock, B. G. (2013) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370016.mt02 · Cited by 8
THERAPEUTIC STRATEGIES FOR BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS (BPSD) IN DEMENTED PATIENTS
Torta, R., BADINO, E., & Scalabrino, A. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.04.057 · Cited by 8
The neuropsychiatric burden of neurological diseases in the elderly
Cummings, J. L. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205002206 · Cited by 8
Behavioral disorders: The ‘blind spot’ of neurology and psychiatry
Azuar, C., & Lévy, R. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.02.083 · Cited by 7
Calvet, B., & Clément, J.-P. (2015) · Presse medicale · doi:10.1016/j.lpm.2014.05.029 · Cited by 7
Treatment of the Neuropsychiatric Symptoms in Alzheimer's Disease
Masterman, D. M. (2003) · Journal of the American Medical Directors Association · doi:10.1016/s1525-8610(04)70406-5 · Cited by 7
Sleep disorders in neurodegenerative diseases other than Parkinson's disease
Auger, R. R., & Boeve, B. F. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52007-4.00020-5 · Cited by 7
Pharmacological Treatment of Challenging Neuropsychiatric Symptoms of Dementia
Woodward, M. C. (2005) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2005.tb00348.x · Cited by 7
Benjamin, S., Ho, J. M.-W., Tung, J., Dholakia, S., An, H., Antoniou, T., Sanger, S., & Williams, J. W. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.05.004 · Cited by 7
Part I: The Psychopharmacology of Long-Term Aggression—Toward an Evidence-Based Algorithm
Bourget, D. (2002) · Cited by 6
Treatment of Alzheimer's disease in Brazil: II. Behavioral and psychological symptoms of dementia
do Vale, F. D. A. C., Neto, Y. C., Bertolucci, P. H. F., Machado, J. C. B., da Silva, D. J., Allam, N., & Balthazar, M. L. F. (2011) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642011dn05030006 · Cited by 6
Chapter 4. Dementia and Milder Cognitive Syndromes
Lyketsos, C. G. (2013) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370016.mt04 · Cited by 6
Uwai, Y., & Nabekura, T. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.07.005 · Cited by 5
Dufresne, C., & Gallarda, T. (2008) · L Encéphale · doi:10.1016/s0013-7006(08)75522-2 · Cited by 5
Délires non schizophréniques du sujet âgé
Pancrazi, M.-P., & Metais, P. (2004) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/s1627-4830(04)97928-7 · Cited by 5
Psychopharmacological Medication Use Among Older Adults with Dementia in Nursing Homes
Brandt, N., & Pyhtila, J. (2013) · Journal of Gerontological Nursing · doi:10.3928/00989134-20130315-05 · Cited by 6
Drugs for disruptive features in dementia
BMJ Publishing Group Ltd (2003) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2003.4111 · Cited by 5
Seibert, M., Holbrook, J. A., & Arnim, C. A. F. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_428 · Cited by 4
Pharmacological alternatives to antipsychotics to manage BPSD
Mishriky, R. S. L., & Reyad, A. A. (2018) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.495 · Cited by 5
Treatment of mood and behavioral disorders in Alzheimer's Disease -
Bourin, M., & Vercelleto, M. (1999) · Psychiatry and Clinical Psychopharmacology · Cited by 4
The Pharmacological Approach of Behavioral Disturbances in Dementia
Maher, R. L. (2004) · Journal of Pharmacy Practice · doi:10.1177/0897190004263316 · Cited by 4
Pharmacological Treatment of Alzheimer’s Disease
Ballard, C. G., Sorensen, S., Aarsland, D., & Alzheimer’s Society, L. (2008) · European Neurological Review · doi:10.17925/enr.2008.03.01.23 · Cited by 4
Carbamazepine Treatment of Hyperactivity and Intrusiveness in Dementia
Stewart, J. T. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000261 · Cited by 4
Behavioural Management in Alzheimer's Disease – Pharmacology
Merrill, D. A., & Sultzer, D. L. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch53 · Cited by 3
Byrne, G. J. (2000) · Current Opinion in Psychiatry · doi:10.1097/00001504-200007000-00009 · Cited by 4
Opioids for agitation in dementia
Brown, R. G., Howard, R. J., Candy, B., & Sampson, E. L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009705 · Cited by 5
Smoller, C., Schiller, E., Yamashita, K. Y., Silverglate, B., & Grossberg, G. T. (2025) · Drugs · doi:10.1007/s40265-025-02227-4 · Cited by 3
Drug Treatments for Alzheimer’s Disease: Hopes and Challenges
Braidy, N., Poljak, A., Jayasena, T., & Sachdev, P. S. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_141 · Cited by 2
Síntomas psicológicos y conductuales asociados a demencias: actualización terapéutica
Slachevsky, A., & Patricio Fuentes, G. (2005) · Revista médica de Chile · doi:10.4067/s0034-98872005001000015 · Cited by 3
Treatment of Dementia: Pharmacological Approaches
Brandt, N., & Mansour, D. Z. (2015) · Springer eBooks · doi:10.1007/978-3-319-18377-0_6 · Cited by 2
Papazoglou, A., Arshaad, M. I., Henseler, C., Daubner, J., Broich, K., Hescheler, J., Ehninger, D., Haenisch, B., & Weiergräber, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073457 · Cited by 3
Chapter 12. Anxiety, Obsessive-Compulsive, and Trauma-Related Disorders
Conroy, M. L., Maruca-Sullivan, P. E., Lane, C. E., & Cook, J. M. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds12 · Cited by 3
Boeve, B. F., & Boxer, A. L. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.016 · Cited by 3
S3-Leitlinie »Demenzen« — Kurzversion
Maier, W., Jessen, F., Schneider, F. W., Deuschl, G., Spottke, A. E., & Reichmann, H. (2010) · Springer eBooks · doi:10.1007/978-3-642-13092-2_3 · Cited by 3
Depression in Alzheimer's Disease
Kwak, Y. T., Yang, Y., & Koo, M. (2014) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2014.13.2.27 · Cited by 3
Psychometric Evaluation of a Proposed Alzheimer’s Aggression Scale
Little, K. G., & Wilks, S. E. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511414553 · Cited by 3
Pharmacological Management of Alzheimer's Disease
Hecker, J. R., & Snellgrov, C. A. (2003) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr200333124 · Cited by 3
Wiltfang, J., Trost, S., & Hampel, H.-J. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_59 · Cited by 3
Traitements médicamenteux des démences sévères
Jouanny, P., Belliard, S., Bentué‐Ferrer, D., Michel, O., & Allain, H. (2005) · Gériatrie et Psychologie Neuropsychiatrie du Viellissement · Cited by 3
Anticonvulsant Use in Treating Dementia-Related Agitation
Gardner, M. E., Ditmanson, L. F., Garrett, R. W., Luu, T., & Meiling, F. (2000) · Journal of Pharmacy Practice · doi:10.1106/vvak-4ttg-lxuc-fdlj · Cited by 3
Fernández, F. V., & Herraiz, M. L. (2001) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(01)74692-6 · Cited by 3
Drugs used to relieve behavioural symptoms of dementia
Ballard, C. G., & Hulford, L. (2004) · Nursing and Residential Care · doi:10.12968/nrec.2004.6.7.13246 · Cited by 3
Part VII. Treatment of neuropsychiatric symptoms in alzheimer's disease
Knopman, D. S. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90008-7 · Cited by 3
Pharmacologic Management of the Chronically Aggressive Psychiatric Patient
Hughes, D. H. (1998) · Psychiatric Annals · doi:10.3928/0048-5713-19980701-06 · Cited by 3
Anticonvulsants to Treat Agitation in Dementia
Tariot, P. N., & Porsteinsson, A. P. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200007092 · Cited by 3
Self-citationAgitation in Patients with Dementia - Challenges in Diagnosis and Treatment
Sommer, O. H. (2010) · NORA - Norwegian Open Research Archives · Cited by 3
Alzheimer's Disease and Mild Cognitive Impairment
Jones, D. T., Bruns, M. B., & Petersen, R. C. (2018) · Wiley eBooks · doi:10.1002/9781118772034.ch21 · Cited by 3
(2003) · CRC Press eBooks · doi:10.1201/b14345-4 · Cited by 3
Aggression, Gewalt, Amok, Stalking infolge psychischer Störungen
Bogerts, B., Peter, E., & Schiltz, K. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_94 · Cited by 2
Malena, K., Rao, S., & Mosler, C. (2024) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2024.300 · Cited by 1
Grube, M. (2000) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s003910070020 · Cited by 2
Medications and Cognition in Older Adults
Caporaso, G. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3106-0_7 · Cited by 2
Maladie d’Alzheimer et troubles psychiatriques
Clément, J., & Nubukpo, P. (2008) · PSN · doi:10.1007/s11836-008-0059-x · Cited by 2
Clinical management of dementia
Ballard, C. G., & Fossey, J. (2008) · Psychiatry · doi:10.1016/j.mppsy.2007.12.007 · Cited by 3
Behavioral Disturbances Associated with Dementia: Nursing Implications
Boyd, M. A. (2001) · Journal of the American Psychiatric Nurses Association · doi:10.1067/mpn.2001.120878 · Cited by 2
Diana, G. (2003) · PubMed · Cited by 2
Assessment and Management of Psychiatric Symptoms in Neurodegenerative Disorders
Rothenberg, K. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-56484-5_23 · Cited by 2
Pharmacological Intervention in Aggression
McQuade, D. V., Barrnett, R. J., & King, B. H. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-382-8_16 · Cited by 2
Chapter 6. Aggression and Violence
Wise, E. A., Lyketsos, C. G., & Onyike, C. U. (2018) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371990.jl06 · Cited by 2
Ballard, C. G., Francis, P. T., & Corbett, A. (2013) · International Psychogeriatrics · doi:10.1017/s1041610213000033 · Cited by 2
Practical clinical use of therapeutic agents for Alzheimer′s disease
Arai, T. (2007) · Folia Pharmacologica Japonica · doi:10.1254/fpj.130.494 · Cited by 2
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg006 · Cited by 2
Suarez, L. S. K., Shafi, R. M. A., & Lapid, M. I. (2019) · OBM Geriatrics · doi:10.21926/obm.geriatr.1903074 · Cited by 2
Medications and Cognition in Older Adults
Caporaso, G. L. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_10 · Cited by 1
Chapter 20. Psychopharmacology
Mulsant, B. H., & Pollock, B. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds20 · Cited by 1
Assessment and Management of Dementia-Related Agitation
Wang, L. Y. (2023) · Current Geriatrics Reports · doi:10.1007/s13670-023-00388-2 · Cited by 1
Repurposing carbamazepine in oncology and rare genetic diseases: A clinical update
Korsavva, S., & Payne, S. (2025) · Oncology and Translational Medicine · doi:10.1097/ot9.0000000000000121 · Cited by 1
Topiramato en el tratamiento de la impulsividad en enfermos mentales ambulatorios
García, C. I., Montila, S. S., Gonzalez, M. H., & Villa, M. J. A. (2005) · Psiquiatría Biológica · Cited by 1
Psychopharmacology of Violence
Kruesi, M. J. P. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511816840.033 · Cited by 1
Gibt es eine Pharmakotherapie von “herausforderndes Verhalten”?
Ceballos-Baumann, A., & Hansmann, J. (2015) · Nervenheilkunde · doi:10.1055/s-0038-1627572 · Cited by 1
Synthesis of Research Findings Regarding Alzheimer's Disease: Part II, Care of People with AD
Bower, F., McCullough, C. S., & Pille, B. (2002) · Worldviews on Evidence-based Nursing presents the archives of Online Journal of Knowledge Synthesis for Nursing · doi:10.1111/j.1524-475x.2002.00060.x
Toolbox: Management of behavioral and psychological symptoms of dementia
Goga, J. K. (2014) · Mental Health Clinician · doi:10.9740/mhc.n204535 · Cited by 1
Sutor, B. (2002) · Comprehensive Therapy · doi:10.1007/s12019-002-0016-x · Cited by 1
Efficacy and Safety of Antidepressant Drugs in Patients with Dementia
Kirshner, H. S. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0222-y · Cited by 2
Demencia con cuerpos de Lewy: diagnóstico, clínica y tratamiento
Calle, M. C. M. (2006) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(06)73247-6 · Cited by 1
Metadata
- Authors
- Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C.
- Affiliations
- University of Rochester Medicine (US)
- Venue
- American Journal of Psychiatry
- Published
- 1998-01-01
- Volume
- 155
- Issue
- 1
- Pages
- 54-61
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2140320787
- Semantic Scholar
- c3da70c064f129607116262314bf832944063d1a
- Cited by
- 422
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 8 · 2023: 3 · 2022: 38 · 2021: 10 · 2020: 8 · 2019: 12 · 2018: 14 · 2017: 14 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 12
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 08665, AG-10463, P60AG010463, P30AG008665)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Keywords
- carbamazepine, dementia, agitation, aggression, nursing home residents, antipsychotic efficacy, drug tolerability, safety, Brief Psychiatric Rating Scale, Clinical Global Impression Scale, staff time, individualized dosing
- MeSH terms
- Aged, Aged, 80 and over, Aggression, Alzheimer Disease, Carbamazepine, Dementia, Drug Administration Schedule, Female, Humans, Male, Nursing Homes, Placebos, Psychiatric Status Rating Scales, Psychomotor Agitation, Dementia, Vascular, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
